Ivy Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Ivy Capital is a premier venture capital and growth equity firm that finances early- or growth-stage companies.
Investor Profile
Ivy Capital has backed more than 11 startups, with 2 new investments in the last 12 months alone. The firm has led 1 rounds, about 9% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Medical, Information Technology, Biotechnology.
- Led 1 rounds in the past year.
Stage Focus
- Series C (36%)
- Series Unknown (27%)
- Series A (18%)
- Series B (9%)
- Series E (9%)
Country Focus
- China (73%)
- United States (27%)
Industry Focus
- Medical
- Information Technology
- Biotechnology
- Health Care
- Software
- Medical Device
- Biopharma
- Clinical Trials
- Cloud Computing
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
